Metabolic switch in hepatocellular carcinoma patients treated with sorafenib: a proof-of-concept trial
2020-01-01 Castello, A; Rimassa, L; Personeni, N; Pressiani, T; Smiroldo, V; Lopci, E
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
2003-01-01 Bozzetti, C.; Personeni, N.; Nizzoli, R.; Guazzi, A.; Flora, M.; Bassano, C.; Negri, F.; Martella, E.; Naldi, N.; Franciosi, V.; Cascinu, S.
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights
2022-01-01 Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
Standardisation of EGFR FISH in colorectal cancer: Results of an international interlaboratory reproducibility ring study
2012-01-01 Sartore Bianchi, A.; Fieuws, S.; Veronese, S.; Moroni, M.; Personeni, N.; Frattini, M.; Torri, V.; Cappuzzo, F.; Vander Borght, S.; Martin, V.; Skokan, M.; Santoro, A.; Gambacorta, M.; Tejpar, S.; Varella Garcia, M.; Siena, S.
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study
2017-01-01 Comito, T; Cozzi, L; Zerbi, A; Franzese, C; Clerici, E; Tozzi, A; Iftode, C; Navarria, P; D'Agostino, G; Fogliata, A; Mancosu, P; Tomatis, S; Carnaghi, C; Personeni, N; Santoro, A; Scorsetti, M
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND)
2019-01-01 Bozzarelli, S; Rimassa, L; Giordano, L; Sala, S; Tronconi, Mc; Pressiani, T; Smiroldo, V; Prete, Mg; Spaggiari, P; Personeni, N; Santoro, A
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma
2023-01-01 Dharmapuri, Sirish; Özbek, Umut; Jethra, Hiren; Jun, Tomi; Marron, Thomas U; Saeed, Anwaar; Huang, Yi-Hsiang; Muzaffar, Mahvish; Pinter, Matthias; Balcar, Lorenz; Fulgenzi, Claudia; Amara, Suneetha; Weinmann, Arndt; Personeni, Nicola; Scheiner, Bernhard; Pressiani, Tiziana; Navaid, Musharraf; Bengsch, Bertram; Paul, Sonal; Khan, Uqba; Bettinger, Dominik; Nishida, Naoshi; Mohamed, Yehia Ibrahim; Vogel, Arndt; Gampa, Anuhya; Korolewicz, James; Cammarota, Antonella; Kaseb, Ahmed; Galle, Peter R; Pillai, Anjana; Wang, Ying-Hong; Cortellini, Alessio; Kudo, Masatoshi; D'Alessio, Antonio; Rimassa, Lorenza; Pinato, David James; Ang, Celina
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
2008-01-01 W, De Roock; H, Piessevaux; J, De Schutter; M, Janssens; G, De Hertogh; Personeni, N.; B, Biesmans; Laethem Jl, Van; M, Peeters; Y, Humblet; E, Van Cutsem; S., Tejpar
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
2022-01-01 Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Himmelsbach, Vera; Schulze, Kornelius; Von Felden, Johann; Fründt, Thorben W; Stadler, Marc; Heinzl, Harald; Shmanko, Kateryna; Spahn, Stephan; Radu, Pompilia; Siebenhüner, Alexander R; Mertens, Joachim C; Rahbari, Nuh N; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias P; Teufel, Andreas; De Dosso, Sara; Pinato, David J; Pressiani, Tiziana; Meischl, Tobias; Balcar, Lorenz; Müller, Christian; Mandorfer, Mattias; Reiberger, Thomas; Trauner, Michael; Personeni, Nicola; Rimassa, Lorenza; Bitzer, Michael; Trojan, Jörg; Weinmann, Arndt; Wege, Henning; Dufour, Jean-François; Peck-Radosavljevic, Markus; Vogel, Arndt; Pinter, Matthias
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study
2008-01-01 Personeni, N.; Fieuws, S.; Piessevaux, H.; De Hertogh, G.; De Schutter, J.; Biesmans, B.; De Roock, W.; Capoen, A.; Debiec Rychter, M.; Van Laethem, J.; Peeters, M.; Humblet, Y.; Van Cutsem, E.; Tejpar, S.
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
2021-01-01 Personeni, Nicola; Pressiani, Tiziana; D'Alessio, Antonio; Prete, Maria Giuseppina; Bozzarelli, Silvia; Terracciano, Luigi; Dal Buono, Arianna; Capogreco, Antonio; Aghemo, Alessio; Lleo, Ana; Lutman, Romano Fabio; Roncalli, Massimo; Giordano, Laura; Santoro, Armando; Di Tommaso, Luca; Rimassa, Lorenza
Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter?
2006-01-01 Personeni, N.
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer
2005-01-01 Personeni, N.; Hendlisz, A.; Gallez, A.; Gomez Galdon, M.; Larsimont, D.; Van Laethem, Ji.; Nagy, N.; Barette, M.; Paesmans, M.; Cardoso, F.; Bleiberg, H.
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
2012-01-01 Personeni, N.; Bozzarelli, S.; Pressiani, T.; Rimassa, L.; Tronconi, M. C.; Sclafani, F.; Carnaghi, C.; Pedicini, V.; Giordano, L.; Santoro, A.
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma
2013-01-01 Personeni, N; Rimassa, L; Pressiani, T; Destro, A; Ligorio, C; Tronconi, Mc; Bozzarelli, S; Carnaghi, C; Di Tommaso, L; Giordano, L; Roncalli, M; Santoro, A
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases
2018-01-01 Vigano, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
2019-01-01 Mazzaferro, V; El-Rayes, Bf; Droz Dit Busset, M; Cotsoglou, C; Harris, Wp; Damjanov N, ; Masi, G; Rimassa, L; Personeni, N; Braiteh, F; Zagonel, V; Papadopoulos, Kp; Hall, T; Wang, Y; Schwartz, B; Kazakin, J; Bhoori, S; De Braud, F; Shaib, Wl
Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing?
2007-01-01 Personeni, N.
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study
2017-01-01 Comito, T.; Cozzi, L.; Zerbi, A.; Franzese, C.; Clerici, E.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Fogliata, A.; Mancosu, P.; Tomatis, S.; Carnaghi, C.; Personeni, N.; Santoro, A.; Scorsetti, M.
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine
2019-01-01 Rimassa, L; Personeni, N; Aghemo, A; Lleo, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Metabolic switch in hepatocellular carcinoma patients treated with sorafenib: a proof-of-concept trial | 1-gen-2020 | Castello, A; Rimassa, L; Personeni, N; Pressiani, T; Smiroldo, V; Lopci, E | |
| HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma | 1-gen-2003 | Bozzetti, C.; Personeni, N.; Nizzoli, R.; Guazzi, A.; Flora, M.; Bassano, C.; Negri, F.; Martella, E.; Naldi, N.; Franciosi, V.; Cascinu, S. | |
| Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights | 1-gen-2022 | Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza | |
| Standardisation of EGFR FISH in colorectal cancer: Results of an international interlaboratory reproducibility ring study | 1-gen-2012 | Sartore Bianchi, A.; Fieuws, S.; Veronese, S.; Moroni, M.; Personeni, N.; Frattini, M.; Torri, V.; Cappuzzo, F.; Vander Borght, S.; Martin, V.; Skokan, M.; Santoro, A.; Gambacorta, M.; Tejpar, S.; Varella Garcia, M.; Siena, S. | |
| Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study | 1-gen-2017 | Comito, T; Cozzi, L; Zerbi, A; Franzese, C; Clerici, E; Tozzi, A; Iftode, C; Navarria, P; D'Agostino, G; Fogliata, A; Mancosu, P; Tomatis, S; Carnaghi, C; Personeni, N; Santoro, A; Scorsetti, M | |
| Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND) | 1-gen-2019 | Bozzarelli, S; Rimassa, L; Giordano, L; Sala, S; Tronconi, Mc; Pressiani, T; Smiroldo, V; Prete, Mg; Spaggiari, P; Personeni, N; Santoro, A | |
| Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma | 1-gen-2023 | Dharmapuri, Sirish; Özbek, Umut; Jethra, Hiren; Jun, Tomi; Marron, Thomas U; Saeed, Anwaar; Huang, Yi-Hsiang; Muzaffar, Mahvish; Pinter, Matthias; Balcar, Lorenz; Fulgenzi, Claudia; Amara, Suneetha; Weinmann, Arndt; Personeni, Nicola; Scheiner, Bernhard; Pressiani, Tiziana; Navaid, Musharraf; Bengsch, Bertram; Paul, Sonal; Khan, Uqba; Bettinger, Dominik; Nishida, Naoshi; Mohamed, Yehia Ibrahim; Vogel, Arndt; Gampa, Anuhya; Korolewicz, James; Cammarota, Antonella; Kaseb, Ahmed; Galle, Peter R; Pillai, Anjana; Wang, Ying-Hong; Cortellini, Alessio; Kudo, Masatoshi; D'Alessio, Antonio; Rimassa, Lorenza; Pinato, David James; Ang, Celina | |
| KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab | 1-gen-2008 | W, De Roock; H, Piessevaux; J, De Schutter; M, Janssens; G, De Hertogh; Personeni, N.; B, Biesmans; Laethem Jl, Van; M, Peeters; Y, Humblet; E, Van Cutsem; S., Tejpar | |
| Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score | 1-gen-2022 | Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Himmelsbach, Vera; Schulze, Kornelius; Von Felden, Johann; Fründt, Thorben W; Stadler, Marc; Heinzl, Harald; Shmanko, Kateryna; Spahn, Stephan; Radu, Pompilia; Siebenhüner, Alexander R; Mertens, Joachim C; Rahbari, Nuh N; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias P; Teufel, Andreas; De Dosso, Sara; Pinato, David J; Pressiani, Tiziana; Meischl, Tobias; Balcar, Lorenz; Müller, Christian; Mandorfer, Mattias; Reiberger, Thomas; Trauner, Michael; Personeni, Nicola; Rimassa, Lorenza; Bitzer, Michael; Trojan, Jörg; Weinmann, Arndt; Wege, Henning; Dufour, Jean-François; Peck-Radosavljevic, Markus; Vogel, Arndt; Pinter, Matthias | |
| Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study | 1-gen-2008 | Personeni, N.; Fieuws, S.; Piessevaux, H.; De Hertogh, G.; De Schutter, J.; Biesmans, B.; De Roock, W.; Capoen, A.; Debiec Rychter, M.; Van Laethem, J.; Peeters, M.; Humblet, Y.; Van Cutsem, E.; Tejpar, S. | |
| Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors | 1-gen-2021 | Personeni, Nicola; Pressiani, Tiziana; D'Alessio, Antonio; Prete, Maria Giuseppina; Bozzarelli, Silvia; Terracciano, Luigi; Dal Buono, Arianna; Capogreco, Antonio; Aghemo, Alessio; Lleo, Ana; Lutman, Romano Fabio; Roncalli, Massimo; Giordano, Laura; Santoro, Armando; Di Tommaso, Luca; Rimassa, Lorenza | |
| Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter? | 1-gen-2006 | Personeni, N. | |
| Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer | 1-gen-2005 | Personeni, N.; Hendlisz, A.; Gallez, A.; Gomez Galdon, M.; Larsimont, D.; Van Laethem, Ji.; Nagy, N.; Barette, M.; Paesmans, M.; Cardoso, F.; Bleiberg, H. | |
| Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma | 1-gen-2012 | Personeni, N.; Bozzarelli, S.; Pressiani, T.; Rimassa, L.; Tronconi, M. C.; Sclafani, F.; Carnaghi, C.; Pedicini, V.; Giordano, L.; Santoro, A. | |
| Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma | 1-gen-2013 | Personeni, N; Rimassa, L; Pressiani, T; Destro, A; Ligorio, C; Tronconi, Mc; Bozzarelli, S; Carnaghi, C; Di Tommaso, L; Giordano, L; Roncalli, M; Santoro, A | |
| Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases | 1-gen-2018 | Vigano, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G | |
| Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma | 1-gen-2019 | Mazzaferro, V; El-Rayes, Bf; Droz Dit Busset, M; Cotsoglou, C; Harris, Wp; Damjanov N, ; Masi, G; Rimassa, L; Personeni, N; Braiteh, F; Zagonel, V; Papadopoulos, Kp; Hall, T; Wang, Y; Schwartz, B; Kazakin, J; Bhoori, S; De Braud, F; Shaib, Wl | |
| Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing? | 1-gen-2007 | Personeni, N. | |
| Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study | 1-gen-2017 | Comito, T.; Cozzi, L.; Zerbi, A.; Franzese, C.; Clerici, E.; Tozzi, A.; Iftode, C.; Navarria, P.; D'Agostino, G.; Fogliata, A.; Mancosu, P.; Tomatis, S.; Carnaghi, C.; Personeni, N.; Santoro, A.; Scorsetti, M. | |
| The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine | 1-gen-2019 | Rimassa, L; Personeni, N; Aghemo, A; Lleo, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista71158
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa66
- 2020 - 202616399
- 2010 - 201922952
- 2000 - 200918285
- 1990 - 19998873
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI965
- Elsevier Ltd746
- Elsevier B.V.640
- MDPI AG497
- Elsevier386
- Springer316
- John Wiley and Sons Inc314
- Multidisciplinary Digital Publish...296
- Springer Science and Business Med...288
- Elsevier Inc.261
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE381
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS272
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...192
- DOCTOR. OS183
- ACTA BIOMEDICA181
- NUTRIENTS179
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2902
- Female1593
- Male1490
- Middle Aged900
- Adult893
- Aged757
- Animals652
- Italy585
- Medicine (all)464
- COVID-19451
Lingua
- eng42927
- ita9076
- fre232
- spa124
- ger99
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext57849
- reserved8054
- open3765
- partially open822
- restricted667
- embargoed2
- mixed1